What is Prostate cancer?

['Umviriza uru rupapuro']

Kanseri y'ibere ni iki?

Kanseri y'ibere ni ubwoko bwa kanseri ikurira mu gihimba c'irondoka c'umugabo, kikaba ari agahimba gatoyi kameze nk'ak'agasaho k'intete mu bagabo gakora intanga.

Ubwo bwoko bwa kanseri ni bumwe mu bwoko bwa kanseri zikunda gufata abagabo, kandi akenshi ikura buhorobuhoro.

Mu bihe bimwebimwe, vyoshobora kudatera ibimenyetso canke bigasaba ko uvurwa.

Ariko rero, hari igihe usanga ari mbi cane ku buryo ishobora no gukwiragira mu bindi bihimba vy'umubiri.

Nta wuzi neza igituma umuntu arwara kanseri y'ibere, ariko hariho ibintu bishobora gutuma umuntu ayirwara, nk'imyaka, umuryango umuntu arimwo n'ubwoko.

Gutahura iyo ndwara hakiri kare no kuyirwanya birahambaye kugira ngo ivure neza.

['Ibitabu vyo muri Bibiliya']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Ankerst DP, Groskopf J, Day JR, Blase A, Rittenhouse H, Pollock BH, Tangen C, Parekh D, Leach RJ, Thompson I: Predicting prostate cancer risk through incorporation of prostate cancer gene 3. J Urol. 2008, 180 (4): 1303-8; discussion 1308.

Plym A, Zhang Y, Stopsack KH, Jee YH, Wiklund F, Kibel AS, Kraft P, Giovannucci E: Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years. Clin Cancer Res. 2022, 28 (22): 4926-4933.

Wang SQ, Huang SS: [Markers of prostate cancer stem cells: research advances]. Zhonghua Nan Ke Xue. 2013, 19 (12): 1133-7.

Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN: Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomarkers Prev. 2012, 21 (1): 53-60.

Abdel-Rahman O: Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial. Clin Genitourin Cancer. 2019, 17 (4): e837-e844.

['Urupapuro rwemeza ko ata ruhusha:']

["Uru rubuga rw'ivy'ubuvuzi ruratangwa ku bw'inyigisho no ku bw'ukumenyesha amakuru gusa, ntirutanga impanuro mu vy'ubuvuzi canke ngo rube urwego rw'abahinga mu vy'ubuvuzi."]

["Amakuru atangwa n'ivyo binyamakuru ntabereye gukoreshwa mu gusuzuma canke mu kuvura ingorane y'amagara canke indwara kanaka, kandi abarondera impanuro zijanye n'ivy'ubuvuzi bakwiye kwitura umuganga abifitiye uruhusha."]

["Urabona ko ubuhinga bwa none butanga inyishu z'ibibazo usanga butarimwo ukuri na canecane igihe ari ibitigiri, nk'akarorero igitigiri c'abantu barwaye indwara kanaka."]

["Niwame usaba impanuro umuganga wawe canke uwundi muntu abifitiye uburenganzira mu bijanye n'amagara yawe. Ntiwigere wirengagiza impanuro z'umuganga canke ngo ureke kuzirondera kubera ivyo wasomye kuri uyu muhora. Nimba wibaza ko hari ikintu cihutirwa mu vy'amagara, nuce uhamagara 911 canke uje aho bavurira indembe hagufi."]

["Igabishwa: uburenganzira bw'abafise ivyo banditse"]

["Itegeko ryo mu 1998 ryerekeye uburenganzira umuntu afise mu vyo akoresha mu guhanahana amakuru (Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) ritanga uburenganzira ku bantu bafise uburenganzira bwo guhanahana amakuru babona ko ibintu vyerekanwa kuri Internet bihonyanga uburenganzira bwabo hisunzwe amategeko ya Leta Zunze Ubumwe za Amerika ajanye n'uburenganzira umuntu afise. "]

['Mu gihe wibaza ko hari ibintu canke ibikoresho vyabonetse ku rubuga rwacu canke ku mbuga zacu bibangamiye uburenganzira bwawe, wewe (canke uwukugenzura) urashobora kuturungikira ubutumwa busaba ko ivyo bintu canke ivyo bikoresho bikurwaho canke ko bitagisubira kuboneka. ']

['Amatangazo ategerezwa kurungikwa mu nyandiko hakoreshejwe ubutumwa bwa "email" (raba ahavuga ngo "Kwitaba" kugira ngo umenye aderese ya "email").']

["Itegeko rya DMCA risaba ko umenyesha ko hari uwugomba guhonyanga uburenganzira bwawe mu gutanga amakuru akurikira: (1) idondorwa ry'igikorwa gikingiwe n'amategeko kiriko kiragirizwa guhonyanga uburenganzira bwawe; (2) idondorwa ry'ibiri mu vyo bavuga ko bihonyanga uburenganzira bwawe be n'amakuru ahagije atuma dushobora kumenya aho biri; (3) amakuru y'ukuntu twokwifatanya nawe, harimwo aderese yawe, inomero za telefone n'ikete ryawe ryo kurungikiranira ubutumwa kuri internet; (4) ivyemeza ko wemera udakeka ko ivyo bintu biri mu buryo uriko uridodombera bitahawe uburenganzira n'uwabitunganije, canke uwubiserukira, canke n'itegeko iryo ari ryo ryose; "]

["(5) urwandiko rwanditswe n'uwatanze iyo notifica-tion, rwemeza ko amakuru ari muri iyo notifica-tion ari ay'ukuri kandi ko afise ububasha bwo gukurikirana ivy'uwo muntu avuga ko yahonyanze uburenganzira bwiwe; "]

["n' (6) umukono w'umuntu canke w'ubuhinga bwa elegitoronike w'uwuri n'ico kintu canke w'umuntu yahawe uburenganzira bwo gukora ku bw'uwo muntu. "]

['Kudashiramwo amakuru yose ari aho haruguru vyoshobora gutuma ivyo kwitwarira umuntu bicererwa.']

['Uwushobora kugufasha']

['Turakwinginze uturungikire ubutumwa kuri email ufise ikibazo / iciyumviro.']

What is prostate cancer?

Prostate cancer is a type of cancer that develops in the prostate gland, which is a small, walnut-shaped gland in men that produces seminal fluid.

This type of cancer is one of the most common types of cancer in men, and it typically grows slowly.

In some cases, it may not cause any symptoms or require treatment.

However, in other cases, it can be aggressive and spread to other parts of the body.

The exact cause of prostate cancer is unknown, but certain risk factors, such as age, family history, and race, can increase a man's likelihood of developing the disease.

Early detection and treatment are important for improving the chances of successful treatment.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.